vs
Community West Bancshares（CWBC）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Community West Bancshares的季度营收约是STANDARD BIOTOOLS INC.的2.0倍（$38.3M vs $19.6M），Community West Bancshares同比增速更快（11.6% vs -11.5%），Community West Bancshares自由现金流更多（$43.6M vs $-23.1M），过去两年Community West Bancshares的营收复合增速更高（36.0% vs -12.2%）
Community West Bancshares是一家总部位于美国加利福尼亚州的注册银行控股公司，依据银行控股公司相关法案全资持有Community West Bank，开展银行相关控股经营业务。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CWBC vs LAB — 直观对比
营收规模更大
CWBC
是对方的2.0倍
$19.6M
营收增速更快
CWBC
高出23.0%
-11.5%
自由现金流更多
CWBC
多$66.7M
$-23.1M
两年增速更快
CWBC
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.3M | $19.6M |
| 净利润 | — | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 40.0% | -168.5% |
| 净利率 | — | -177.4% |
| 营收同比 | 11.6% | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $0.58 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CWBCLAB
| Q4 25 | $38.3M | — | ||
| Q3 25 | $37.9M | $19.6M | ||
| Q2 25 | $35.7M | $21.8M | ||
| Q1 25 | $34.8M | $40.8M | ||
| Q4 24 | $34.3M | — | ||
| Q3 24 | $31.3M | $22.1M | ||
| Q2 24 | $30.5M | $22.5M | ||
| Q1 24 | $20.7M | $45.5M |
净利润CWBCLAB
| Q4 25 | — | — | ||
| Q3 25 | $10.9M | $-34.7M | ||
| Q2 25 | $7.8M | $-33.5M | ||
| Q1 25 | $8.3M | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $3.4M | $-26.9M | ||
| Q2 24 | $-6.3M | $-45.7M | ||
| Q1 24 | $3.7M | $-32.2M |
毛利率CWBCLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率CWBCLAB
| Q4 25 | 40.0% | — | ||
| Q3 25 | 39.8% | -168.5% | ||
| Q2 25 | 30.2% | -118.1% | ||
| Q1 25 | 32.7% | -80.8% | ||
| Q4 24 | 31.0% | — | ||
| Q3 24 | 13.3% | -120.9% | ||
| Q2 24 | -25.9% | -134.5% | ||
| Q1 24 | 23.2% | -132.2% |
净利率CWBCLAB
| Q4 25 | — | — | ||
| Q3 25 | 28.7% | -177.4% | ||
| Q2 25 | 22.0% | -153.7% | ||
| Q1 25 | 23.8% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | -122.0% | ||
| Q2 24 | -20.7% | -203.3% | ||
| Q1 24 | 17.8% | -70.6% |
每股收益（稀释后）CWBCLAB
| Q4 25 | $0.58 | — | ||
| Q3 25 | $0.57 | $-0.09 | ||
| Q2 25 | $0.41 | $-0.09 | ||
| Q1 25 | $0.44 | $-0.07 | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $0.18 | $-0.07 | ||
| Q2 24 | $-0.33 | $-0.12 | ||
| Q1 24 | $0.31 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $119.0M | $129.4M |
| 总债务越低越好 | $69.5M | — |
| 股东权益账面价值 | $409.6M | $399.7M |
| 总资产 | $3.7B | $539.6M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资CWBCLAB
| Q4 25 | $119.0M | — | ||
| Q3 25 | $121.6M | $129.4M | ||
| Q2 25 | $134.4M | $158.6M | ||
| Q1 25 | $148.4M | $150.9M | ||
| Q4 24 | $120.4M | — | ||
| Q3 24 | $149.0M | $210.6M | ||
| Q2 24 | $109.7M | $269.8M | ||
| Q1 24 | $61.0M | $287.1M |
总债务CWBCLAB
| Q4 25 | $69.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $69.9M | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益CWBCLAB
| Q4 25 | $409.6M | — | ||
| Q3 25 | $397.6M | $399.7M | ||
| Q2 25 | $380.0M | $424.5M | ||
| Q1 25 | $372.2M | $454.6M | ||
| Q4 24 | $362.7M | — | ||
| Q3 24 | $363.5M | $489.3M | ||
| Q2 24 | $350.2M | $510.3M | ||
| Q1 24 | $211.7M | $577.3M |
总资产CWBCLAB
| Q4 25 | $3.7B | — | ||
| Q3 25 | $3.6B | $539.6M | ||
| Q2 25 | $3.6B | $557.0M | ||
| Q1 25 | $3.6B | $579.6M | ||
| Q4 24 | $3.5B | — | ||
| Q3 24 | $3.5B | $681.5M | ||
| Q2 24 | $3.5B | $708.7M | ||
| Q1 24 | $2.4B | $777.7M |
负债/权益比CWBCLAB
| Q4 25 | 0.17× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $43.6M | $-23.1M |
| 自由现金流率自由现金流/营收 | 113.9% | -118.1% |
| 资本支出强度资本支出/营收 | 6.6% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $77.7M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CWBCLAB
| Q4 25 | $46.1M | — | ||
| Q3 25 | $13.2M | $-22.2M | ||
| Q2 25 | $11.5M | $-20.7M | ||
| Q1 25 | $11.1M | $-30.3M | ||
| Q4 24 | $22.2M | — | ||
| Q3 24 | $7.8M | $-27.9M | ||
| Q2 24 | $5.2M | $-39.0M | ||
| Q1 24 | $4.0M | $-62.5M |
自由现金流CWBCLAB
| Q4 25 | $43.6M | — | ||
| Q3 25 | $12.8M | $-23.1M | ||
| Q2 25 | $10.6M | $-22.6M | ||
| Q1 25 | $10.8M | $-35.3M | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $5.2M | $-30.1M | ||
| Q2 24 | $4.8M | $-41.0M | ||
| Q1 24 | $3.6M | $-63.3M |
自由现金流率CWBCLAB
| Q4 25 | 113.9% | — | ||
| Q3 25 | 33.7% | -118.1% | ||
| Q2 25 | 29.6% | -103.6% | ||
| Q1 25 | 30.9% | -86.6% | ||
| Q4 24 | 50.0% | — | ||
| Q3 24 | 16.7% | -136.4% | ||
| Q2 24 | 15.7% | -182.2% | ||
| Q1 24 | 17.3% | -138.9% |
资本支出强度CWBCLAB
| Q4 25 | 6.6% | — | ||
| Q3 25 | 1.1% | 4.5% | ||
| Q2 25 | 2.7% | 8.7% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 8.1% | 10.2% | ||
| Q2 24 | 1.4% | 8.6% | ||
| Q1 24 | 2.1% | 1.7% |
现金转化率CWBCLAB
| Q4 25 | — | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CWBC
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
